Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001628280-19-006435

Results of operations

  • Item 2.02 Results of operations and financial condition

From the SEC's structured data for this filing

Loading q12019pressrelease.htm…